Self-testing Diagnosis Imaging Model for Diabetic Retinopathy
NCT ID: NCT05223556
Last Updated: 2023-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
167 participants
OBSERVATIONAL
2022-02-01
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Within one week of receiving both diagnostic imaging services, patient preferences are assessed and they decide which diagnostic imaging model is preferred.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
OCT-Based Screening for Early Retinal Changes in Asymptomatic Diabetic Patients
NCT07232225
Multimodal Biomarkers in Prediction of Diabetic Retinopathy
NCT07098832
Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application
NCT03899623
Real-world Diagnostic Effectiveness of Artificial Intelligence Algorithm in Diabetic Retinopathy Screening
NCT03911323
Evaluation System and Clinical Application for Diabetic Retinopathy
NCT03528720
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Shaoguan Diabetic cohort
Patients with diabetes ages 30-80 were enrolled in Shaoguan Diabetic Eye Screening Programme, who will receive diabetic retinopathy screening both in a remote diagnostic imaging site and in a tertiary hospital
Full Self-Diagnostic device in a remote diagnostic imaging site
Full Self-Diagnostic CRP+OCT imaging, followed by online consultation
Human imager operated diagnostic device in the hospital
Human imager operated CRP imaging with dilated pupils, followed by face-to-face consultation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Full Self-Diagnostic device in a remote diagnostic imaging site
Full Self-Diagnostic CRP+OCT imaging, followed by online consultation
Human imager operated diagnostic device in the hospital
Human imager operated CRP imaging with dilated pupils, followed by face-to-face consultation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. who are diagnosed with diabetes and aged between 30 years and 80 years
3. be able to sit for an imaging device for image acquisition
4. be capable of giving their own consent
Exclusion Criteria
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhongshan Ophthalmic Center, Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020KYPJ201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.